ATP13A2 Antikörper (Ser282)
Kurzübersicht für ATP13A2 Antikörper (Ser282) (ABIN1822805)
Target
Alle ATP13A2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Ser282
-
Spezifität
- Endogenous levels of total human PARK9. Species Crossreactivity: Monkey, mouse and rat.
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Synthetic peptide corresponding to residues surrounding Ser282 of human PARK9.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: IP (1:50), WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM sodium HEPES, pH 7.5, 150 mM sodium chloride, 100 μg/mL BSA, 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
-
Andere Bezeichnung
- ATP13A2
-
Hintergrund
-
Name/Gene ID: ATP13A2
Subfamily: ATPase - P type, type V
Family: Transporter
Synonyms: ATP13A2, HSA9947, PARK9, RP1-37C10.4, Putative ATPase, ATPase type 13A2, CLN12, KRPPD -
Gen-ID
- 23400
-
UniProt
- Q9NQ11
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-